Unilex Lifesciences Private Limited - Company Profile

It is a pharma private limited company based in Panampilly Nagar, Kerala, India, established in 2011.
2011 Panampilly Nagar, Kerala, India Active
Last Updated:
Access Report
About Unilex Lifesciences Private Limited

Unilex Lifesciences Private Limited, a active private limited company, was established on 06 September 2011 in Panampilly Nagar, Kerala, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24233KL2011PTC029307. Registered under ROC Roc Ernakulam. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Employing 41 professional, Its leadership includes Vimalkumar Viswanathan (Director), Suraj Premraj (Director), Rajesh Kumar Rajan (Managing Director). Past directors included Vimalkumar Viswanathan, Jyothish Kanth Sukumaran, Muhammedlabba Chempakasseril Faisal Mussaliyar. It holds ₹2.14 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 38/455 (New No. 63/2503, Anjiparambil Building, Ground Floor, Near Manorama Junction ,, Panampilly Nagar, Kerala, 682016.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24233KL2011PTC029307

  • Registration Number

    029307

  • Incorporation Date

    06 September 2011

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Ernakulam

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 14 Year, 5 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 2.14 Cr
  • Revenue Growth **** 33.75%
  • Profit Growth **** 51.44%
  • Ebitda **** 61.89%
  • Net Worth 37.82%
  • Total Assets **** 37.21%
Company report

Unilex Lifesciences Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Unilex Lifesciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Unilex Lifesciences Private Limited?
Current Directors
Name Designation Appointment Date Status
Vimalkumar Viswanathan Director 14 Jun 2013 Current
Suraj Premraj Director 28 Aug 2019 Current
Rajesh Kumar Rajan Managing Director 10 Aug 2012 Current
Narendrakurup Sarasamma Gopakumar Director 25 Jul 2016 Current
Hashim Kaithakalathil Director 06 Sep 2011 Current
Rajesh Radha Krishnan Director 22 Dec 2016 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 29 Sep 2013 Past
Pramod Abcsdd Director 12 Sep 2015 Past
Pramod Abcsdd Director 14 Feb 2018 Past
Pramod Abcsdd Managing Director 14 Feb 2018 Past
Pramod Abcsdd Additional Director 30 Sep 2019 Past
Pramod Abcsdd Director 01 Feb 2018 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Unilex Lifesciences.

Unilex Lifesciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 33.75% increase. The company also saw a substantial improvement in profitability, with a 51.44% increase in profit. The company's net worth Soared by an impressive increase of 37.82%.

Unilex Lifesciences revenue growth over time
Unilex Lifesciences profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 33.75%
*******
*******
*******
*******
Revenue from Operations
*******
 33.75%
*******
*******
*******
*******
Total Assets
*******
 37.21%
*******
*******
*******
*******
Profit or Loss
*******
 51.44%
*******
*******
*******
*******
Net Worth
*******
 37.82%
*******
*******
*******
*******
EBITDA
*******
 61.89%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Unilex Lifesciences?

Unlock access to Unilex Lifesciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹21,418,923.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 1.95 Cr
  • Others : 0.19 Cr
Latest Charge Details
Date Lender Amount Status
23 Jul 2025 Hdfc Bank Limited ₹3.04 M Open
14 May 2025 Hdfc Bank Limited ₹3.63 M Open
31 Jan 2025 Hdfc Bank Limited ₹2.14 M Open
17 Jul 2024 Hdfc Bank Limited ₹0.82 M Open
11 Dec 2023 Hdfc Bank Limited ₹1.31 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Unilex Lifesciences?

Unilex Lifesciences has a workforce of 41 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Unilex Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Unilex Lifesciences's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Unilex Lifesciences
Recent Activity within the Organization
  • Annual General Meeting

    The activity Unilex Lifesciences Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Charges

    Progress on A charge with Hdfc Bank Limited amounted to Rs. 3.04 M with Charge ID 101147277 was registered on 23 Jul 2025. was documented.

  • Charges

    The activity A charge with Hdfc Bank Limited amounted to Rs. 3.63 M with Charge ID 101099317 was registered on 14 May 2025. was completed.

  • Balance Sheet

    The activity Unilex Lifesciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ernakulam. was completed.

  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 2.14 M with Charge ID 101041853 was registered on 31 Jan 2025. was recorded as a recent event.

  • Charges

    The activity A charge with Hdfc Bank Limited amounted to Rs. 0.82 M with Charge ID 100949748 was registered on 17 Jul 2024. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Unilex Lifesciences Private Limited?

The CIN of Unilex Lifesciences Private Limited is U24233KL2011PTC029307.

Where is Unilex Lifesciences Private Limited headquartered?

Unilex Lifesciences Private Limited is headquartered at 38/455 (New No. 63/2503, Anjiparambil Building, Ground Floor, Near Manorama Junction ,, Panampilly Nagar, Kerala, 682016.

When was Unilex Lifesciences Private Limited incorporated?

Unilex Lifesciences Private Limited was incorporated on 06 September 2011.

Who are the current directors of Unilex Lifesciences Private Limited?

The current directors of Unilex Lifesciences Private Limited are

What is the primary industry of Unilex Lifesciences Private Limited?

The primary industry of Unilex Lifesciences Private Limited is Trade.

Is Unilex Lifesciences Private Limited a listed company?

Unilex Lifesciences Private Limited is unlisted.

What is the capital structure of Unilex Lifesciences Private Limited?

The authorized capital of Unilex Lifesciences Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Unilex Lifesciences Private Limited?

The compliance status of Unilex Lifesciences Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available